Weight loss effectiveness Average weight loss expectations: 0.5mg daily: 8-10% over 24 weeks 1.0mg daily: 10-12% over 24 weeks Starting weight ~220 lbs: Lose 22-26 lbs Better than most weight loss medications Similar to GLP-1 agonists Individual variation: Timeline for weight loss: Week 1-2: 2-4 lbs (water weight + appetite suppression ) Week 3-4: 1-2 lbs/week (fat loss beginning) Month 2-3: 1-1.5 lbs/week (steady loss) Month 4-6: 0.5-1 lb/week (slowing, approaching plateau) Month 6-9: 0-0.5 lb/week (maintenance/plateau) Total: 20-30 lbs typical over 6 months Body composition changes: Primarily fat loss (75-80% of loss) Some muscle loss (20-25%) - unavoidable in deficit Better muscle preservation than pure caloric restriction Waist circumference reduction significant Visceral fat preferentially lost See peptides before and after results and how long peptides take to work

PubMed laboratory research record [PMID: 39757501] PubMed record related to this compound for laboratory literature review
Rybelsus should be used with caution in patients with severe kidney dysfunction Semaglutide should not be used in individuals with a personal or family history of Medullary Thyroid Carcinoma (MTC) or in those with Multiple Endocrine Neoplasia syndrome type 2
These agents target multiple metabolic pathways involved in appetite regulation, insulin secretion, glucose homeostasis, and energy expenditure, making them particularly relevant for adolescents with obesity and associated metabolic complications
Harlan M
Preterm infants are not efficient in their energy use, a poor exogenous nutrient supply during the first few days of life may not only lead to extrauterine growth retardation in newborns, but it may also increase their susceptibility to infectious diseases and organ function damage (80)